Evidence map›Paper›PMID 36643972›Full record

ArticleFrontiers in nutrition2022

The modification of individual factors on association between serum 25(OH)D and incident type 2 diabetes: Results from a prospective cohort study.

Zhiyong Hu, Xueyuan Zhi, Yiming Ma, Jiafu Li, Jinxiu Wang, Jianliang Zhu, Bingyan Li, Zengli Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhiyong HuSchool of Public Health and Management, Binzhou Medical University, Yantai, China.
Xueyuan ZhiDepartment of Occupational and Environmental Health, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
Yiming MaDepartment of Occupational and Environmental Health, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
Jiafu LiDepartment of Occupational and Environmental Health, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
Jinxiu WangSchool of Public Health and Management, Binzhou Medical University, Yantai, China.
Jianliang ZhuLishui Center for Disease Control and Prevention, Lishui, China.
Bingyan LiDepartment of Nutrition and Food Hygiene, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
Zengli ZhangDepartment of Occupational and Environmental Health, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several epidemiological studies have suggested an association between low vitamin D status and increased risk for type 2 diabetes (T2D). This study aimed to explore the dose-response relationship of serum 25-hydroxyvitamin D [25(OH)D] concentrations with incident T2D and the interaction between serum 25(OH)D with individual factors on T2D risk. A total of 1,926 adults without diabetes (mean age: 52.08 ± 13.82 years; 42% men) were prospectively followed for 36 months. Cox proportional hazards model and restricted cubic spline analysis were performed to assess the association and dose-response relationship between serum 25(OH)D and T2D incidence. Both additive and multiplicative interactions were calculated between serum 25(OH)D and individual factors. The net reclassification index (NRI) was used to evaluate the improvement of risk prediction of T2D by adding serum 25(OH)D to traditional risk factors. There were 114 new T2D cases over a mean follow-up of 36 months. Serum 25(OH)D was not associated with T2D incidence, and no significant dose-response relationship was found in the total population. However, stratified analyses suggested a non-linear inverse relationship among individuals with baseline fasting plasma glucose (FPG) <5.6 mmol/L (

Indexed as

interactionphysical activityrisk reclassificationtype 2 diabetesvitamin D

Identifiers

PMID36643972
PMCPMC9835095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.